Sulfonate-Containing Thiiranes as Selective Gelatinase Inhibitors
摘要:
Matrix metalloproteinases (MMPs) are important zinc-dependent endopeptidases. Two members of this family of enzymes called gelatinases (MMP-2 and MMP-9) have been implicated in a number of human diseases, including cancer, neurological and cardiovascular diseases, and inflammation to name a few. We describe in this report the preparation and evaluation of two structural types of thiirane inhibitors that show selectivity toward gelatinases. The biphenyl series targets both gelatinases, whereas the monophenyl analogues exhibit potent inhibition of only MMP-2. The latter structural type also exhibits improved water solubility and metabolic stability, both traits desirable for progress of these molecules forward in gelatinase-dependent animal models of disease.
Sulfonate-Containing Thiiranes as Selective Gelatinase Inhibitors
摘要:
Matrix metalloproteinases (MMPs) are important zinc-dependent endopeptidases. Two members of this family of enzymes called gelatinases (MMP-2 and MMP-9) have been implicated in a number of human diseases, including cancer, neurological and cardiovascular diseases, and inflammation to name a few. We describe in this report the preparation and evaluation of two structural types of thiirane inhibitors that show selectivity toward gelatinases. The biphenyl series targets both gelatinases, whereas the monophenyl analogues exhibit potent inhibition of only MMP-2. The latter structural type also exhibits improved water solubility and metabolic stability, both traits desirable for progress of these molecules forward in gelatinase-dependent animal models of disease.
Pyrazoline derivatives useful for the treatment of cancer
申请人:Cuberes Altisen Rosa
公开号:US20070066651A1
公开(公告)日:2007-03-22
Compounds of formula (I) wherein: X is selected from the group consisting of trihalomethyl, C
1
-C
6
alkyl, and a group of formula (II) wherein: R
3
and R
4
are independently selected from the group consisting of hydrogen; halogen; hydroxyl; nitro; C
1
-C
6
alkyl; C
1
-C
6
alkoxy; carboxy; C
1
-C
6
trihaloalkyl; and cyano; Z is selected from the group consisting of substituted and unsubstituted aryl; or a pharmaceutically acceptable salt thereof. The compounds are inhibitors of cyclooxygenase-2 activity. They are useful for treating cyclooxygenase-mediated disorders, including, for example, inflamation, neoplastic disorders and angiogenesis-mediated disorders.